Live
- Kamada Ekadashi 2024: Date, Auspicious Timings And Significance
- Aamir Khan’s son Junaid wraps up filming for his second movie
- Vijay Sethupathi’s heartwarming gesture wins netizens’ hearts
- Excitement builds as Nabha Natesh and Priyadarshi paired up
- Gurinder Chadha all set to make a comeback to big screen
- Palle Sindhura Reddy flays YS Jagan during election campaign in Puttaparthi
- KK Raju files nomination amid public celebrations and predicts victory with 45k vote majority
- Vijayawada Central Candidate Vellampally Srinivas Campaigns in 28th Division Railway Colony
- DCA busts three quack clinics in Hyd, Jangaon and Mahabubnagar
- Man threatens to jump into lake if he doesn’t get divorced from his wife
Aurobindo injection gets Food and Drug Administration nod
Highlights
Aurobindo Pharma on Monday said it has received approval from the US health regulator to manufacture and market Bivalirudin injection, an anticoagulant medication, in the American market
Hyderabad: Aurobindo Pharma on Monday said it has received approval from the US health regulator to manufacture and market Bivalirudin injection, an anticoagulant medication, in the American market.
The company has received final approval from the US Food and Drug Administration (USFDA) for its product which is a generic version of The Medicines Company's Angiomax injection, the Hyderabad-based firm said in a statement.
The product will be launched in September 2018, it added. According to IQVIA, the estimated market size for Bivalirudin injection stood at $101 million for the 12 months ending May 2018.
Next Story
ADVERTISEMENT
